Q1 2022 13F Holders as of 3/31/2022
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
42.9M
-
Number of holders
-
284
-
Total 13F shares, excl. options
-
49.5M
-
Shares change
-
-1.14M
-
Total reported value, excl. options
-
$3.77B
-
Value change
-
-$68M
-
Put/Call ratio
-
9.12
-
Number of buys
-
152
-
Number of sells
-
-117
-
Price
-
$76.32
Significant Holders of Pacira BioSciences, Inc. - Common Stock, par value $0.001 per share (PCRX) as of Q1 2022
319 filings reported holding PCRX - Pacira BioSciences, Inc. - Common Stock, par value $0.001 per share as of Q1 2022.
Pacira BioSciences, Inc. - Common Stock, par value $0.001 per share (PCRX) has 284 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 49.5M shares
.
Largest 10 shareholders include BlackRock Inc. (6.97M shares), VANGUARD GROUP INC (4.69M shares), MACQUARIE GROUP LTD (4.06M shares), BAILLIE GIFFORD & CO (2.12M shares), Spyglass Capital Management LLC (1.87M shares), RENAISSANCE TECHNOLOGIES LLC (1.86M shares), STATE STREET CORP (1.61M shares), LOOMIS SAYLES & CO L P (1.29M shares), Stephens Investment Management Group LLC (1.16M shares), and Clearbridge Investments, LLC (1.13M shares).
This table shows the top 284 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.